Atai Life Sciences has re-filed with the SEC to increase its IPO financing from $100 to $246 million. It's a big deal.
Articles
Getting People to Help Changes Everything: William Cook, CEO of MindLeap
Mydecine Innovations Group is a psychedelics company that The Dales Report has been watching closely this past year.
Texas And Louisiana Governors Signal They’ll Sign Marijuana Reform Bills On Their Desks
The governors of Texas and Louisiana on Thursday separately indicated that they will sign marijuana reform bills that have recently been delivered to their desks.
Magic Mushrooms Helped Me Cope With Postpartum Depression
In 2014, during my first pregnancy, I felt happy and healthy almost all the time.
Heritage Cannabis launches weed-infused freezies for summer
Just in time for summer, Heritage Cannabis Holdings Corp. has announced the launch of RADsicles, a cannabis-infused frozen edible meant to help consumers beat the heat with an intoxicating twist.
Entheon Biomedical's Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US
HaluGen Life Sciences' test evaluates an individual's overall sensitivity and risk profile associated with psychedelic-assisted therapy
MindMed’s New CEO Well-Prepared For Next Stage of Corporate Development
Co-Founder JR Rahn has stepped down as CEO of MindMed. His replacement, Robert Barrow, brings a wealth of clinical trials experience.
MindMed Announces Chief Executive Officer Transition
JR Rahn is stepping down as MindMed's CEO, to be replaced by Chief Development Officer, Robert Barrow.
Inflation Capitulation Signals Dollar’s Demise, Gold’s Rise
Central banks aren't "accepting" higher levels of price inflation. They are being run over by it.
Massachusetts Approves Cannabis Delivery with Focus on Equity
Massachusetts Cannabis Control Commission launches new delivery licenses, awarding access to those who need it most.
Seattle City Council Promotes Psychedelics As Potential Tool Against Opioid Epidemic
Seattle lawmakers on Monday sent a letter to members of a local task force focused on the opioid overdose epidemic, imploring the group to investigate the therapeutic potential of psychedelics like ayahuasca and ibogaine in curbing addiction.
Red Light Holland Closes Acquisition of Cutting Edge Silicon Valley Applied Sciences Company Radix Motion, Becoming a Leader in Psychedelic Technology
Red Light Holland's new tech acquisition is intended to help optimize psychedelics dosing.
Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms
Mydecine announces identifying 40 previously unknown "novel compounds" among dozens of mushroom species it has screened.
Optimi Health Announces Product Distribution Agreement with Vitasave
Optimi Health's new distribution agreement with Vitasave provides retail access to two of Canada's largest urban markets.
Field Trip Health Ltd. Applies to List Its Common Shares on the NASDAQ Stock Market
After just uplisting to the TSX in Canada, Field Trip Health has applied to uplist to the NASDAQ in the U.S.